19 / June / 2026 AI shifts from competitive edge to key competence for researchers ResearchComp update highlights the need for researchers across all fields to understand the uses, limitations, and risks of the technology Por Daniel Dieb
16 / June / 2026 Electroacupuncture may help treat chemotherapy-induced pain Phase 3 study presented at the ASCO Annual Meeting evaluates the technique as a nonpharmacological alternative for peripheral neuropathy in cancer patients Por Samuel Antenor
12 / June / 2026 “An endangered species”: what is driving physician-scientists out of science? Survey of 230 US professionals finds that 49% are considering leaving research, for reasons beyond lack of funding Por Gilberto Stam
11 / June / 2026 ChatGPT and other AI redefine scientific literature review Study shows how tools such as ChatGPT, Elicit, and Research Rabbit can speed up literature reviews without replacing researcher analysis Por Arthur Almeida
10 / June / 2026 Cancer clinical trials grow more slowly than expected in Brazil, study finds A 20-year analysis shows that the country has made progress but still faces regulatory and cultural barriers, as well as reliance on the pharmaceutical industry. Por Gabriela Monteiro
08 / June / 2026 Doctoral students in health-related fields are trained for research but poorly prepared for leadership International survey reveals a lack of consistent leadership development initiatives in health-related PhD programs Por Gilberto Stam
05 / June / 2026 Predatory journals exploit pressure on Brazilian researchers to publish A study of more than a thousand researchers shows how questionable journals exploit the “publish or perish” culture to attract submissions Por Daniel Dieb
04 / June / 2026 Frontier science takes risk, but Brazil still punishes failure Experts say that truly innovative projects require safer environments in which to make mistakes, recombine knowledge, and challenge paradigms Por Daniel Dieb
03 / June / 2026 Daraxonrasib: the story of a drug that took 44 years to develop A New York Times report chronicles four decades of research culminating in the development of daraxonrasib, a drug that doubled the overall survival of patients with metastatic pancreatic cancer Por Diogo Rodriguez
01 / June / 2026 Vocation, collaboration, and family: what motivates physicians to continue in or leave research? With half of medical specialists holding a PhD, the Netherlands offers an insight into why so few physicians continue in research and what separates those who do from those who leave science behind Por Daniel Dieb
